|
Search
Collections
Benchmarks
Upload document
Organization
ARUP Laboratories
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
7 posters
Poster
Changes in mast cell numbers and phenotype in patients with indolent systemic mastocytosis treated with avapritinib
Poster
PIONEER: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy
Poster
An Updated Analysis on Safety and Efficacy of Avapritinib in Patients With Advanced Systemic Mastocytosis From the EXPLORER Clinical Study: Long-term Efficacy and Safety
Poster
AZURE: A Phase 1/2 Study of BLU-263 as Monotherapy and in Combination With Azacitidine in Patients With Advanced Systemic Mastocytosis
Poster
Effect of avapritinib on skin disease burden in patients with advanced systemic mastocytosis (AdvSM): A novel, artificial intelligence (AI)-based technology
Poster
Results from PIONEER: A Randomized, Double-blind, Placebo-controlled, Phase 2 Study of Avapritinib in Patients with Indolent Systemic Mastocytosis
Poster
Responses to Avapritinib in Patients With Advanced Systemic Mastocytosis: Histopathologic Analyses From EXPLORER and PATHFINDER Clinical Studies